.svg){kind=small}
May-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Market Insights Snapshot
In May 2026, Lobo’s category mix tilted toward Flower at 54.73% share with year-over-year growth of 32.16% and month-over-month growth of 14.45%, while Concentrates expanded to 20.96% share with 151.03% YoY and 52.44% MoM increases; in contrast, Pre-Roll fell to 24.32% share with a 59.06% YoY decline and a 9.99% MoM decline. Despite an overall brand sales decline of 8.45% YoY and a 9.40% YoY drop in average price, the rank of 61 in Flower within New York indicates that growth in higher-velocity segments (Flower and Concentrates) is partially offsetting weakness in Pre-Roll; the pattern implies Lobo is reallocating demand toward formats with improving sell-through while exiting lower-yield Pre-Roll volume.
The acceleration in Concentrates (151.03% YoY and 52.44% MoM) alongside Flower gains (32.16% YoY and 14.45% MoM) and concurrent price compression (average price down 9.40% YoY, Flower price at $45.85) suggests a trade-up on potency and a value recalibration rather than broad expansion, given brand sales are still down 8.45% YoY and 35.01% over 24 months. With Pre-Roll contracting 59.06% YoY and 9.99% MoM while Flower holds a 54.73% share and Lobo sits at rank 61 in New York Flower, the mix shift implies a positioning pivot toward core inhalables where differentiation can lift rank efficiency, using Concentrates as the growth wedge and Flower as the volume anchor.
Competitive Landscape
Lobo sits at rank #61 in NY Flower in May 2026, improving 3 positions from #64 year over year, but down 9 spots from #52 in February 2026 and well off its peak rank of #40 from May 2024; meanwhile, Leal moved up from #11 to #1 with 109.3% YoY sales growth and RYTHM advanced from #10 to #4 with 45.8% YoY growth, while Dank. By Definition slipped from #1 to #2 alongside a -38.1% YoY sales decline. The juxtaposition of Lobo’s modest YoY rank gain alongside multi-rank climbs by competitors indicates Lobo is stabilizing rather than recapturing share, implying that without a shift in velocity or assortment, its trajectory points toward further mid-pack drift.
Notable Products
Pop Rocks Badder (1g) posted the standout movement in May 2026 with a 61.6% month-over-month gain and climbed into the number 4 rank, while Blue Dream Diamond Infused Pre-Roll 5-Pack (2.5g) fell 13.7% and sat at number 3. Gelonade Moonrocks (3.5g) held the top slot at rank 1 despite a 5.2% decline, and Sour Diesel Hashish (1g) rose 30.1% to secure rank 2 with approximately $31,468 in sales. Three Concentrates SKUs landed in the top five, and two Pre-Roll SKUs ranked in the top eight, indicating a product mix shifting toward higher-potency formats and away from value-oriented multi-pack pre-rolls.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
